Nasdaq biol.
BIOLASE, Inc. (NASDAQ:BIOL) posted its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share for the quarter, topping analysts' consensus estimates of ($75.00) by $25.00. The medical technology company had revenue of $9.53 million for the quarter.
03 Mar, 2021, 09:00 ET. IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced today that the company has formed a community of ...FOOTHILL RANCH, Calif., Sept. 8, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced its schedule of investor conferences for September 2021 ...Dec 1, 2023 · Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Confira a cotação BIOL hoje e acompanhe as ações BIOLASE em tempo real. As seções dessa página permitem ver o preço da ação agora, comparar com dados históricos, ver gráficos, dividendos e indicadores importantes sobre as ações BIOLASE Inc negociadas na Bolsa de Valores NASDAQ.Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...
BIOL’s shares have dropped by -21.84% in the last five days, while they have subtracted -8.67% in the last month. Further, it is currently trading at a price-to-book ratio of 1.12. LORD JONATHAN T MD, Director, of BIOLASE Inc. (BIOL), sold 11,038 BIOLASE Inc. stock in an exchange on Dec 15.Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...Biolase, Inc. is estimated to report earnings on 11/09/2022. The upcoming earnings date is derived from an algorithm based on a company's historical reporting …
How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997.
NEW YORK, NY / ACCESSWIRE / March 25, 2021 / BIOLASE, Inc. (NASDAQ:BIOL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 4:30 ...TradingView India. View live Biolase, Inc. chart to track its stock's price action. Find market predictions, BIOL financials and market news.COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the …Jan 31, 2023 · Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.
Nov 22, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ...
BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units ...
May 11, 2023 · LAKE FOREST, Calif., May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023 ... BIOL. BIOLASE, Inc. 1.2400. +0.0200. +1.64%. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript March 28, 2023 Operator: Greetings. Welcome to the BIOLASE 2022 Fourth Quarter and Full ...Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific ...Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced the FDA 510(k) clearance of the Ed gePRO system for endodontists seeking a more effective cleaning and disinfection alternative within root canal procedures. The new laser …
BIOL Biolase Inc Form 8-K - Current report BIOLASE, INC false 0000811240 0000811240 2023-11-14 2023-11-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...FOOTHILL RANCH, Calif., Feb. 23, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the Board of Directors has appointed John R. Beaver, the ...Feb 4, 2021 · According to the recent notification letter, the staff of NASDAQ has determined that for the last ten consecutive business days, from January 21, 2021 to February 3, 2021, the closing bid price of ... FOOTHILL RANCH, Calif., Sept. 11, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the ...
Gainers Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares jumped 537.5% to close at $25.50 on Wednesday after the company priced its IPO at $4 per share.Source: Kantar Media. Advertisement. Biolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary.
Stock Ratings Screener · Free Ratings Newsletter. This page (NASDAQ:BIOL) was last updated on 11/30/2023 by ...BIOL U.S.: Nasdaq Biolase Inc. Watch list NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:47 p.m. EST Delayed quote $ 1.1600 0.01 0.87% After Hours Volume: 175 Advanced... The 36-month beta value for BIOL is also noteworthy at 1.33. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”. The average price estimated by analysts for BIOL is $16.33, which is $14.66 above than the current price.BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...Dec 1, 2023 · Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. These institutions hold a total of 1 shares. Largest shareholders include Huntington National Bank . Biolase Inc (NASDAQ:BIOL) institutional ownership structure ...FOOTHILL RANCH, Calif., Feb. 23, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the Board of Directors has appointed John R. Beaver, the ...Oct 20, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No ...
BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.
LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously ...
BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.CAMBRIDGE, Mass., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today …Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFOOTHILL RANCH, Calif., Dec. 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that it will be presenting at the 13th annual LD Micro Main ...NASDAQNYSEIBEX35LSEDAXCRYPTO. Buscar. NASDAQ:BIOL. BIOLASE Inc. Sector. Health. Industry. Medical supplies and equipment. 1,65 $ Last price. -0,03 $ VARIATION.BIOL Biolase Inc stock NASDAQ ... Shares Out. ... biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in ...Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Price, Quote, News & History | Nasdaq. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p ...BIOLASE, Inc. (NASDAQ:BIOL) rose 11.9% to settle at $0.4700 after Nasdaq granted the company 180-day extension to meet minimum bid price requirement. The company also entered into favorable credit ...Mar 1, 2022 · 01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ... BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...
BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...Gainers BIOLASE, Inc. (NASDAQ:BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said i...Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.Instagram:https://instagram. how to trade currency onlinesimply safe dividendbiggest ai stocksschd calculator NASDAQNYSEIBEX35LSEDAXCRYPTO. Buscar. NASDAQ:BIOL. BIOLASE Inc. Sector. Health. Industry. Medical supplies and equipment. 1,65 $ Last price. -0,03 $ VARIATION.Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. mumu tradingbank stocks list /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be presenting at the Benchmark Company Discovery... wefunder review Jan 31, 2023 · Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. Nov 8, 2023 · Biolase Inc (NASDAQ:BIOL) trade information. Instantly BIOL has been showing a green trend so far today with a performance of 5.70% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.7500 on Tuesday, 11/07/23 increased the stock’s daily price by 4.57%.